SCHEMBL4395583

SCHEMBL4395583

COc1ccc(Nc2cc(Oc3ccc([N+](=O)[O-])cc3)ncn2)cc1.O=[N+]([O-])c1ccc(Oc2cc(Cl)ncn2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.55
RAB9A P51151 3/20 0.55
MEN1 O00255 7/20 0.52
KMT2A Q03164 7/20 0.52
ALDH1A1 P00352 1/20 0.46
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
EGFR P00533 2/20 0.46
ERBB2 P04626 1/20 0.46
PIK3CA P42336 1/20 0.46
PIK3CB P42338 1/20 0.46
PIK3CG P48736 1/20 0.46
GSK3B P49841 1/20 0.44
PDCD1 Q15116 1/20 0.44
CD274 Q9NZQ7 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.44
TTBK1 Q5TCY1 1/20 0.43
TTBK2 Q6IQ55 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3166433 0.94 NPC1 (0.60) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL3260635 0.89 NPC1 (0.55) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL4345309 0.89 EGFR (0.47) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL12664955 0.85 RAB9A (0.48) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL4929503 0.84 KMT2A (0.58) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL3172396 0.83 ALK (0.50) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL1894480 0.83 MEN1 (0.52) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL1898323 0.83 RAB9A (0.46) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL1891269 0.82 RAB9A (0.50) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL12481913 0.81 NPC1 (0.56) NPC1RAB9AMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1511730-B8 DIARYL UREA DERIVATIVES USEFUL FOR THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES NOVARTIS AG (CH) 2009-04-08 EP disclosed
EP-1511730-A2 DIARYL UREA DERIVATIVES USEFUL FOR THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES Novartis AG (CH) 2005-03-09 EP disclosed
WO-2003099771-A2 DIARYL UREA DERIVATIVES USEFUL FOR THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES NOVARTIS AG (CH) 2003-12-04 WO disclosed